LXEO
Price
$6.77
Change
+$0.27 (+4.15%)
Updated
Sep 26 closing price
Capitalization
365.59M
78 days until earnings call
SLDB
Price
$6.15
Change
+$0.23 (+3.89%)
Updated
Sep 26 closing price
Capitalization
478.89M
Interact to see
Advertisement

LXEO vs SLDB

Header iconLXEO vs SLDB Comparison
Open Charts LXEO vs SLDBBanner chart's image
Lexeo Therapeutics
Price$6.77
Change+$0.27 (+4.15%)
Volume$707.96K
Capitalization365.59M
Solid Biosciences
Price$6.15
Change+$0.23 (+3.89%)
Volume$1.18M
Capitalization478.89M
LXEO vs SLDB Comparison Chart in %
Loading...
LXEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLDB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LXEO vs. SLDB commentary
Sep 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LXEO is a Buy and SLDB is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 29, 2025
Stock price -- (LXEO: $6.77 vs. SLDB: $6.15)
Brand notoriety: LXEO and SLDB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LXEO: 128% vs. SLDB: 108%
Market capitalization -- LXEO: $365.59M vs. SLDB: $478.89M
LXEO [@Biotechnology] is valued at $365.59M. SLDB’s [@Biotechnology] market capitalization is $478.89M. The market cap for tickers in the [@Biotechnology] industry ranges from $98.9B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LXEO’s FA Score shows that 0 FA rating(s) are green whileSLDB’s FA Score has 2 green FA rating(s).

  • LXEO’s FA Score: 0 green, 5 red.
  • SLDB’s FA Score: 2 green, 3 red.
According to our system of comparison, SLDB is a better buy in the long-term than LXEO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LXEO’s TA Score shows that 4 TA indicator(s) are bullish while SLDB’s TA Score has 5 bullish TA indicator(s).

  • LXEO’s TA Score: 4 bullish, 3 bearish.
  • SLDB’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, LXEO is a better buy in the short-term than SLDB.

Price Growth

LXEO (@Biotechnology) experienced а +31.46% price change this week, while SLDB (@Biotechnology) price change was +20.12% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.00%. For the same industry, the average monthly price growth was +9.18%, and the average quarterly price growth was +54.60%.

Reported Earning Dates

LXEO is expected to report earnings on Dec 15, 2025.

Industries' Descriptions

@Biotechnology (+4.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SLDB($479M) has a higher market cap than LXEO($366M). SLDB YTD gains are higher at: 53.750 vs. LXEO (2.888). LXEO has higher annual earnings (EBITDA): -111.97M vs. SLDB (-152.11M). SLDB has more cash in the bank: 268M vs. LXEO (133M). LXEO has less debt than SLDB: LXEO (8.91M) vs SLDB (23.1M). LXEO (0) and SLDB (0) have equivalent revenues.
LXEOSLDBLXEO / SLDB
Capitalization366M479M76%
EBITDA-111.97M-152.11M74%
Gain YTD2.88853.7505%
P/E RatioN/AN/A-
Revenue00-
Total Cash133M268M50%
Total Debt8.91M23.1M39%
FUNDAMENTALS RATINGS
SLDB: Fundamental Ratings
SLDB
OUTLOOK RATING
1..100
17
VALUATION
overvalued / fair valued / undervalued
1..100
23
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
43
P/E GROWTH RATING
1..100
3
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LXEOSLDB
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
82%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
77%
Momentum
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
83%
MACD
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 3 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 3 days ago
81%
Advances
ODDS (%)
Bullish Trend 5 days ago
88%
Bullish Trend 5 days ago
79%
Declines
ODDS (%)
N/A
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
LXEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLDB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IITSF6.550.16
+2.58%
Intesa Sanpaolo S.p.A.
CTNR5.00N/A
N/A
Central Natural Resources, Inc.
LIFX32.00N/A
N/A
Life360 Inc.
NNWWF34.58-0.39
-1.12%
North West Company, Inc. (The)
TSKFF0.92-0.02
-2.18%
Talisker Resources Ltd.

LXEO and

Correlation & Price change

A.I.dvisor indicates that over the last year, LXEO has been loosely correlated with COGT. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if LXEO jumps, then COGT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LXEO
1D Price
Change %
LXEO100%
+4.15%
COGT - LXEO
44%
Loosely correlated
+6.55%
TERN - LXEO
44%
Loosely correlated
+2.69%
RGNX - LXEO
44%
Loosely correlated
+3.10%
SLDB - LXEO
43%
Loosely correlated
+3.89%
IPSC - LXEO
43%
Loosely correlated
+4.39%
More

SLDB and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLDB has been loosely correlated with EDIT. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if SLDB jumps, then EDIT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLDB
1D Price
Change %
SLDB100%
+3.89%
EDIT - SLDB
47%
Loosely correlated
+0.31%
BEAM - SLDB
46%
Loosely correlated
-0.52%
ALLO - SLDB
45%
Loosely correlated
+4.17%
DSGN - SLDB
44%
Loosely correlated
+7.53%
SYRE - SLDB
44%
Loosely correlated
+4.04%
More